Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase... von Seiwert, Tanguy Y, Dr, Burtness, Barbara, MD, Mehra, Ranee, Weiss, Jared, MD, Berger, Raanan, MD, Eder, Joseph Paul, MD, Heath, Karl, MPH, McClanahan, Terrill, PhD, Lunceford, Jared, PhD, Gause, Christine, PhD, Cheng, Jonathan D, MD, Chow, Laura Q, MD

Volltext

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study von Nanda, Rita, Chow, Laura Q M, Dees, E Claire, Berger, Raanan, Gupta, Shilpa, Geva, Ravit, Pusztai, Lajos, Pathiraja, Kumudu, Aktan, Gursel, Cheng, Jonathan D, Karantza, Vassiliki, Buisseret, Laurence

Volltext

Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study von Bauml, Joshua, Seiwert, Tanguy Y, Pfister, David G, Worden, Francis, Liu, Stephen V, Gilbert, Jill, Saba, Nabil F, Weiss, Jared, Wirth, Lori, Sukari, Ammar, Kang, Hyunseok, Gibson, Michael K, Massarelli, Erminia, Powell, Steven, Meister, Amy, Shu, Xinxin, Cheng, Jonathan D, Haddad, Robert

Volltext

IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade von Ayers, Mark, Lunceford, Jared, Nebozhyn, Michael, Murphy, Erin, Loboda, Andrey, Kaufman, David R, Albright, Andrew, Cheng, Jonathan D, Kang, S Peter, Shankaran, Veena, Piha-Paul, Sarina A, Yearley, Jennifer, Seiwert, Tanguy Y, Ribas, Antoni, McClanahan, Terrill K

Volltext

FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells von Lee, Hyung-Ok, Mullins, Stefanie R, Franco-Barraza, Janusz, Valianou, Matthildi, Cukierman, Edna, Cheng, Jonathan D

Volltext

Clinical outcomes with therapies for previously treated recurrent/metastatic head-and-neck squamous cell carcinoma (R/M HNSCC): A systematic literature review von Lala, Mallika, Chirovsky, Diana, Cheng, Jonathan D., Mayawala, Kapil

Volltext

Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study von Hsu, Chiun, Lee, Se-Hoon, Ejadi, Samuel, Even, Caroline, Cohen, Roger B, Le Tourneau, Christophe, Mehnert, Janice M, Algazi, Alain, van Brummelen, Emilie M J, Saraf, Sanatan, Thanigaimani, Pradeep, Cheng, Jonathan D, Hansen, Aaron R

Volltext

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer von Mehnert, Janice M, Varga, Andrea, Brose, Marcia S, Aggarwal, Rahul R, Lin, Chia-Chi, Prawira, Amy, de Braud, Filippo, Tamura, Kenji, Doi, Toshihiko, Piha-Paul, Sarina A, Gilbert, Jill, Saraf, Sanatan, Thanigaimani, Pradeep, Cheng, Jonathan D, Keam, Bhumsuk

Volltext

PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer von Yearley, Jennifer H, Gibson, Christopher, Yu, Ni, Moon, Christina, Murphy, Erin, Juco, Jonathan, Lunceford, Jared, Cheng, Jonathan, Chow, Laura Q M, Seiwert, Tanguy Y, Handa, Masahisa, Tomassini, Joanne E, McClanahan, Terrill

Volltext

Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 E... von Chow, Laura Q M, Haddad, Robert, Gupta, Shilpa, Mahipal, Amit, Mehra, Ranee, Tahara, Makoto, Berger, Raanan, Eder, Joseph Paul, Burtness, Barbara, Lee, Se-Hoon, Keam, Bhumsuk, Kang, Hyunseok, Muro, Kei, Weiss, Jared, Geva, Ravit, Lin, Chia-Chi, Chung, Hyun Cheol, Meister, Amy, Dolled-Filhart, Marisa, Pathiraja, Kumudu, Cheng, Jonathan D, Seiwert, Tanguy Y

Volltext

Alzheimer’s Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies von Shieh, Jonathan Chang-Cheng, Huang, Pai-Tsang, Lin, Yung-Feng

Volltext

Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy von Cristescu, Razvan, Mogg, Robin, Ayers, Mark, Albright, Andrew, Murphy, Erin, Yearley, Jennifer, Sher, Xinwei, Liu, Xiao Qiao, Lu, Hongchao, Nebozhyn, Michael, Zhang, Chunsheng, Lunceford, Jared K, Joe, Andrew, Cheng, Jonathan, Webber, Andrea L, Ibrahim, Nageatte, Plimack, Elizabeth R, Ott, Patrick A, Seiwert, Tanguy Y, Ribas, Antoni, McClanahan, Terrill K, Tomassini, Joanne E, Loboda, Andrey, Kaufman, David

Volltext

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer von Kim, Seung Tae, Cristescu, Razvan, Bass, Adam J., Kim, Kyoung-Mee, Odegaard, Justin I., Kim, Kyung, Liu, Xiao Qiao, Sher, Xinwei, Jung, Hun, Lee, Mijin, Lee, Sujin, Park, Se Hoon, Park, Joon Oh, Park, Young Suk, Lim, Ho Yeong, Lee, Hyuk, Choi, Mingew, Talasaz, AmirAli, Kang, Peter Soonmo, Cheng, Jonathan, Loboda, Andrey, Lee, Jeeyun, Kang, Won Ki

Volltext

Fleshing Out Models of Gender in English-Language Novels (1850 – 2000) von Cheng, Jonathan

Volltext

Activatable Near-Infrared Fluorescent Probe for In Vivo Imaging of Fibroblast Activation Protein-alpha von Li, Jinbo, Chen, Kai, Liu, Hongguang, Cheng, Kai, Yang, Meng, Zhang, Jiping, Cheng, Jonathan D, Zhang, Yan, Cheng, Zhen

Volltext

Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer von Mehnert, Janice M, Panda, Anshuman, Zhong, Hua, Hirshfield, Kim, Damare, Sherri, Lane, Katherine, Sokol, Levi, Stein, Mark N, Rodriguez-Rodriquez, Lorna, Kaufman, Howard L, Ali, Siraj, Ross, Jeffrey S, Pavlick, Dean C, Bhanot, Gyan, White, Eileen P, DiPaola, Robert S, Lovell, Ann, Cheng, Jonathan, Ganesan, Shridar

Volltext

Experimental pub crawl from Rayleigh–Bénard to magnetostrophic convection von Grannan, Alexander M., Cheng, Jonathan S., Aggarwal, Ashna, Hawkins, Emily K., Xu, Yufan, Horn, Susanne, Sánchez-Álvarez, Jose, Aurnou, Jonathan M.

Volltext

Pembrolizumab in Asia‐Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE‐012 von Tahara, Makoto, Muro, Kei, Hasegawa, Yasuhisa, Chung, Hyun Cheol, Lin, Chia‐Chi, Keam, Bhumsuk, Takahashi, Kenichi, Cheng, Jonathan D., Bang, Yung‐Jue

Volltext

Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study von Harrington, Kevin J, Kong, Anthony, Mach, Nicolas, Chesney, Jason A, Fernandez, Beatriz Castelo, Rischin, Danny, Cohen, Ezra E W, Radcliffe, Hoi-Shen, Gumuscu, Burak, Cheng, Jonathan, Snyder, Wendy, Siu, Lillian L

Volltext

The Vitamin D Metabolite Ratio (VMR) is a Biomarker of Vitamin D Status That is Not Affected by Acute Changes in Vitamin D Binding Protein von Dugar, Anushree, Hoofnagle, Andrew N, Sanchez, Amber P, Ward, David M, Corey-Bloom, Jody, Cheng, Jonathan H, Ix, Joachim H, Ginsberg, Charles

Volltext